Company

Bryleos

Biotechnology Research 207 North Boone Street 8 employees

Employees: 8
Contacts: 3
Emails: 3
Phones: 2

www.bryleos.com LinkedIn Crunchbase

Bryleos Overview

Headquarters: 207 North Boone Street
Website: www.bryleos.com
Industry: Biotechnology Research
Employees: 8
Founded: 2021
Funding: 5.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

neuroscience Parkinson's Alzheimer's Multiple Sclerosis neuropsychiatry Metabolic Disorder ALS

About Bryleos

Early clinical stage therapeutics company developing BRY101, a metabolic modulator engineered to increase intracellular NAD, impacting mitochondrial dysfunction, neuroinflammation and oxidative stress. BRY101 impacts multiple pathways simultaneously, breaking away from the traditional single-target drug development model. This strategy is designed to address the complex mechanisms involved in neurodegenerative and neuromuscular disorders. Bryleos: More Life While Living

Bryleos Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Bryleos Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ethy Levy		Israel	Email Phone
Wendy Komac	CEO & Co-founder at Bryleos - Innovating Longevity with Bry101, a Metabolic Modulator Engineered to Increase Intracellular Nad Levels, Targeting	Johnson City, Tennessee, United States	Email Phone
Alpa (Desai) Chokshi	Strategic Marketing Executive - Brand Management - Innovation - Pharma - Healthcare - Us & Global - Professor	New York City Metropolitan Area, United States	Email
Mia Nease, Dba	Technology I Healthcare I Life Science I Data Science I AI I Doctor of Business (Dba)		View